Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jasmin Wilhelmi"'
Autor:
Dennis Niebel, Joerg Wenzel, Dagmar Wilsmann-Theis, Jana Ziob, Jasmin Wilhelmi, Christine Braegelmann
Publikováno v:
Dermatopathology, Vol 8, Iss 4, Pp 463-476 (2021)
(1) Background: Coronavirus disease 2019 (COVID-19) vaccines are currently employed on a population-wide scale in most countries worldwide. Data about unusual cutaneous adverse drug reactions (ADR) are scant, though. (2) Methods: We retrospectively a
Externí odkaz:
https://doaj.org/article/c939f16c5c8949f18afd979201eb3184
Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective
Autor:
Dennis Niebel, Natalija Novak, Jasmin Wilhelmi, Jana Ziob, Dagmar Wilsmann-Theis, Thomas Bieber, Joerg Wenzel, Christine Braegelmann
Publikováno v:
Vaccines, Vol 9, Iss 9, p 944 (2021)
(1) Background: Numerous vaccines are under preclinical and clinical development for prevention of severe course and lethal outcome of coronavirus disease 2019 (COVID-19). In light of high efficacy rates and satisfactory safety profiles, some agents
Externí odkaz:
https://doaj.org/article/71ed619227ae4c3480a3bf049293b086
Autor:
Jana Ziob, Joerg Wenzel, Dennis Niebel, Jasmin Wilhelmi, Dagmar Wilsmann-Theis, Christine Braegelmann
Publikováno v:
Dermatopathology, Vol 8, Iss 49, Pp 463-476 (2021)
Dermatopathology
Volume 8
Issue 4
Pages 49-476
Dermatopathology
Volume 8
Issue 4
Pages 49-476
(1) Background: Coronavirus disease 2019 (COVID-19) vaccines are currently employed on a population-wide scale in most countries worldwide. Data about unusual cutaneous adverse drug reactions (ADR) are scant, though. (2) Methods: We retrospectively a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d1e670505635539e7c2c4f123eb8d1e
https://www.mdpi.com/2296-3529/8/4/49
https://www.mdpi.com/2296-3529/8/4/49
Autor:
Thomas Bieber, Kristel Jaschke, Dennis Niebel, Jana Ziob, Jasmin Wilhelmi, Christine Braegelmann, Luka de Vos, Joerg Wenzel
Publikováno v:
The Journal of Dermatology
Effective vaccines for prevention of severe course and lethal outcome of coronavirus disease 2019 have been developed and approved in regulatory rolling and fast‐track procedures; they are now widely distributed worldwide. Data about cutaneous side
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c852d8b0bc2cd454f96138d48976ddce
https://pubmed.ncbi.nlm.nih.gov/34693548
https://pubmed.ncbi.nlm.nih.gov/34693548
Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective
Autor:
Thomas Bieber, Natalija Novak, Joerg Wenzel, Dennis Niebel, Jana Ziob, Jasmin Wilhelmi, Dagmar Wilsmann-Theis, Christine Braegelmann
Publikováno v:
Vaccines
Vaccines, Vol 9, Iss 944, p 944 (2021)
Vaccines, Vol 9, Iss 944, p 944 (2021)
(1) Background: Numerous vaccines are under preclinical and clinical development for prevention of severe course and lethal outcome of coronavirus disease 2019 (COVID-19). In light of high efficacy rates and satisfactory safety profiles, some agents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3079a5ca11bfd6624775733bac22d0af
https://pubmed.ncbi.nlm.nih.gov/35567368
https://pubmed.ncbi.nlm.nih.gov/35567368